Nattokinase(NATTO)
Enzyme derived from fermented soy used for cardiovascular health.
2 Insights
Investment Insights
AI-generated insights about Nattokinase from various financial sources
Monday, April 27, 2026
Very Bullish
Clinical trials at doses of 10,000 units show potential to reverse arterial plaque.
Very Bullish
Target: 10,000 units daily
Clinical trials suggest high doses can reverse arterial plaque, representing a significant preventative health opportunity.
Monday, April 27, 2026
Very Bullish
Clinical trials at doses of 10,000 units show potential to reverse arterial plaque.
Very Bullish
Target: 10,000 units daily
Clinical trials suggest high doses can reverse arterial plaque, representing a significant preventative health opportunity.